Complete Response to Neoadjuvant Chemoradiation for Rectal Cancer Does Not Influence Survival

@article{Onaitis2001CompleteRT,
  title={Complete Response to Neoadjuvant Chemoradiation for Rectal Cancer Does Not Influence Survival},
  author={Mark W. Onaitis and R. Barrett Noone and BS RyanFields and H. Hurwitz and Michael Morse and MB ChBPaulJowell and Kevin J. McGrath and Catherine Coyle Lee and Mitchell Steven Anscher and Bryan Clary and Christopher R. Mantyh and Theodore N. Pappas and Kirk Ludwig and Hilliard F. Seigler and Douglas S. Tyler},
  journal={Annals of Surgical Oncology},
  year={2001},
  volume={8},
  pages={801-806}
}
Background: Up to 30% of patients with locally advanced rectal cancer have a complete clinical or pathologic response to neoadjuvant chemoradiation. This study analyzes complete clinical and pathologic responders among a large group of rectal cancer patients treated with neoadjuvant chemoradiation. Methods: From 1987 to 2000, 141 consecutive patients with… CONTINUE READING